Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07578857Completed
Randomised trial in hyperlipidemia (4 arms), sponsored by Riphah International University. Primary endpoint: Improvement in Lipid Profile at 3 months. Started May 2023; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07578857.